Causir la lenga
Americas
English (English) Kreyòl Ayisyen (Haitian Creole) Português (Brasil) (Portuguese (Brazil)) Español (Spanish)
Euròpa
Afrikaans (Afrikaans) Shqip (Albanian) Հայերեն (Armenian) Azərbaycanca (Azerbaijani) башҡорт (Bashkir) Euskara (Basque) Беларуская (Belarusian) Bosanski (Bosnian) brezhoneg (Breton) Български (Bulgarian) Català (Catalan) Hrvatski (Croatian) Čeština (Czech) Dansk (Danish) Nederlands (Dutch) Esperanto (Esperanto) Eesti (Estonian) Føroyskt (Faroese) Suomi (Finnish) Français (French) Galego (Galician) Deutsch (German) Ελληνικά (Greek) Magyar (Hungarian) Íslenska (Icelandic) Gaeilge (Irish) Italiano (Italian) Latina (Latin) Latviešu (Latvian) Lietuvių (Lithuanian) Lëtzebuergesch (Luxembourgish) Македонски (Macedonian) Malti (Maltese) Norsk (Norwegian) Norsk bokmål (Norwegian Bokmål) occitan (Occitan) Polski (Polish) Português (Portuguese) Română (Romanian) Русский (Russian) Српски (Serbian) Slovenčina (Slovak) Slovenščina (Slovenian) Svenska (Swedish) татар (Tatar) Türkçe (Turkish) Türkmen (Turkmen) Українська (Ukrainian) Cymraeg (Welsh)
Asia e Pacific
অসমীয়া (Assamese) বাংলা (Bengali) မြန်မာ (Burmese) 简体中文 (Chinese (Simplified)) 繁體中文 (Chinese (Traditional)) ქართული (Georgian) ગુજરાતી (Gujarati) ʻŌlelo Hawaiʻi (Hawaiian) हिन्दी (Hindi) Bahasa Indonesia (Indonesian) 日本語 (Japanese) Jawa (Javanese) ಕನ್ನಡ (Kannada) Қазақ (Kazakh) ខ្មែរ (Khmer) 한국어 (Korean) Кыргызча (Kyrgyz) ລາວ (Lao) Bahasa Melayu (Malay) മലയാളം (Malayalam) Māori (Maori) मराठी (Marathi) Монгол (Mongolian) नेपाली (Nepali) ଓଡ଼ିଆ (Odia) ਪੰਜਾਬੀ (Punjabi) संस्कृत भाषा (Sanskrit) සිංහල (Sinhala) Basa Sunda (Sundanese) Tagalog (Tagalog) Тоҷикӣ (Tajik) தமிழ் (Tamil) తెలుగు (Telugu) ไทย (Thai) བོད་སྐད་ (Tibetan) Oʻzbekcha (Uzbek) Tiếng Việt (Vietnamese)
Orient Mejan e Africa
አማርኛ (Amharic) العربية (Arabic) Hausa (Hausa) עברית (Hebrew) Igbo (Igbo) Kinyarwanda (Kinyarwanda) Kurdî (Kurdish) lingála (Lingala) Malagasy (Malagasy) پښتو (Pashto) فارسی (Persian) chiShona (Shona) سنڌي (Sindhi) Soomaali (Somali) Kiswahili (Swahili) ትግርኛ (Tigrinya) اردو (Urdu) Wolof (Wolof) isiXhosa (Xhosa) ייִדיש (Yiddish) Yorùbá (Yoruba) isiZulu (Zulu)

Pharmacology Made Simple - 6 CEUs Approved by GACA #26-900-33

Understand how drugs affect the brain and apply it directly to real-world addiction counseling.

Pharmacology Made Simple - 6 CEUs... Pharmacology Made Simple - 6... Pharmacology Made... Georgia Reentry Center
$ 65 . 00 Pagar amb Stripe

Qué aprendretz?

Lesson 1 - Foundations and Counselor Role
Foundations and Counselor Role
lock
Contengut de la classa
Vidèo
How Substances Affect the Brain and Body
Methods of Drug Administration
lock
Contengut de la classa
Vidèo
Pharmacokinetics ADME Explained
lock
Contengut de la classa
Vidèo
Pharmacology Foundations (Deep Dive)
lock
Contengut de la classa
Vidèo
Alcohol & Depressants
Alcohol and Depressants
lock

🔷 ALCOHOL


🔹 CLINICALLY OBSERVABLE SYMPTOMS (What You Can See)

 

  • Slurred or slowed speech
  • Poor coordination / unsteady gait
  • Delayed reaction time
  • Impaired judgment and decision-making
  • Disinhibition (risk-taking, inappropriate behavior)
  • Mood swings (euphoria → irritability → depression)
  • Drowsiness or sedation
  • Blackouts or memory gaps
  • Flushed skin
  • Nausea or vomiting
  • Tremors (especially during withdrawal)
  • Sweating
  • Anxiety or agitation (withdrawal phase)
  • Confusion or disorientation
  • Hallucinations (in severe withdrawal)
  • Seizures (advanced withdrawal)
  • Yellowing of skin/eyes (jaundice in liver disease)
  • Abdominal pain (pancreatitis or liver issues)
  • Noticeable weight loss (chronic use)
  • Signs of malnutrition
  • Sleep disturbances (insomnia, fragmented sleep)

 


🔹 SHORT-TERM EFFECTS

 

  • Relaxation and reduced anxiety
  • Lowered inhibitions
  • Impaired coordination and motor control
  • Slowed reflexes
  • Decreased cognitive functioning
  • Impaired memory formation (blackouts)
  • Altered judgment and risk-taking behavior
  • Increased likelihood of accidents or injuries
  • Disrupted sleep cycle (initial sedation → later restlessness)
  • Increased likelihood of unsafe sexual behavior
  • Increased risk of violence or impulsive behavior
  • Hypoglycemia risk (especially after binge drinking)
  • Temporary cardiovascular effects:
    • Increased heart rate
    • Irregular heartbeat

 


🔹 LONG-TERM EFFECTS (DETAILED SYSTEMS BREAKDOWN)


🫀 Cardiovascular System

  • Weakening of the heart muscle (cardiomyopathy)
  • Reduced ability of the heart to pump blood effectively
  • High blood pressure due to vessel constriction
  • Irregular or rapid heartbeat (arrhythmias)
  • Increased risk of stroke
  • Increased risk of heart disease

🧠 Brain & Neurological Effects

  • Accelerated brain aging
  • Shrinkage of frontal lobes (affects decision-making, impulse control)
  • Learning and memory impairment
  • Reduced executive functioning
  • Cognitive decline across lifespan

🔸 Wernicke-Korsakoff Syndrome:

  • Caused by thiamine (Vitamin B1) deficiency
  • Two-stage condition:
    • Wernicke encephalopathy (acute)
    • Korsakoff syndrome (chronic memory disorder)
  • Symptoms include:
    • Confusion
    • Memory loss
    • Poor coordination
    • Eye movement abnormalities

🧬 Cancer Risk

  • Increased risk due to weakened immune system
  • Common cancers linked to alcohol:
    • Esophagus
    • Mouth
    • Throat
    • Larynx (voice box)
  • Increased risk of:
    • Colon cancer
    • Rectal cancer
  • Women:
    • Increased risk of breast cancer with 2+ drinks/day

🍽️ Digestive System

  • Chronic heartburn
  • Stomach ulcers
  • Gastrointestinal bleeding

🔸 Pancreas:

  • Inflammation (pancreatitis)
  • Severe abdominal pain
  • Weight loss
  • Risk of:
    • Diabetes
    • Death (if untreated)

🍬 Blood Sugar & Metabolic Effects

  • Disruption of glucose regulation
  • Increased risk of hypoglycemia (low blood sugar)
  • Can occur 6–36 hours after binge drinking
  • Increased risk when:
    • Drinking without eating
  • Can be life-threatening if untreated

🧬 Hormonal & Reproductive Effects

🔸 Males:

  • Reduced testosterone levels
  • Testicular shrinkage
  • Infertility
  • Impotence
  • Feminization effects:
    • Breast enlargement
    • Reduced facial/body hair
    • Fat redistribution

🔸 Females:

  • Irregular menstrual cycles
  • Failure to ovulate
  • Increased risk of:
    • Miscarriage
    • Early menopause
  • Increased breast cancer risk
  • Increased risk of STDs due to impaired judgment

🫁 Liver Function

🔸 Fatty Liver:

  • Early stage from excess alcohol buildup

🔸 Alcoholic Hepatitis:

  • Liver inflammation
  • Symptoms:
    • Fever
    • Jaundice
    • Abdominal pain
  • Potentially reversible with abstinence

🔸 Cirrhosis:

  • Permanent scarring of liver
  • Prevents toxin filtering
  • Cannot be reversed
  • Can lead to death
  • May require transplant

😴 Sleep & Respiratory Effects

  • Disrupts sleep architecture
  • Initial sedation → later insomnia
  • Reduced restorative sleep
  • Increased risk of sleep apnea

🔸 Sleep Apnea Risks:

  • Airway narrowing during sleep
  • Reduced oxygen to brain
  • Alcohol worsens:
    • Duration of apnea episodes
  • Combined risk increases:
    • Heart attack
    • Stroke
    • Sudden death

🔹 HOW THE CLIENT MAY PRESENT (CLINICAL PATTERNS)

  • Minimizes use (“I only drink socially”)
  • Uses alcohol for coping (anxiety, sleep, stress)
  • Appears functional early, declines over time
  • Memory gaps / blackouts
  • Emotional instability
  • Poor follow-through in treatment
  • Repeated legal or interpersonal issues
  • Denial despite clear consequences
  • Physical decline (weight loss, jaundice, fatigue)
  • Sleep complaints
  • Increased risk-taking behaviors
Contengut de la classa
Vidèo
Opioids and Overdose Risk
Opioids and Overdose Risk
lock

🔷 OPIOIDS


🔹 CLINICALLY OBSERVABLE SYMPTOMS (What You Can See)

🔸 Intoxication / Active Use

  • Constricted (pinpoint) pupils
  • Drowsiness or “nodding off”
  • Slowed or shallow breathing
  • Slurred speech
  • Reduced alertness
  • Drooping eyelids
  • Decreased pain response
  • Poor coordination
  • Itching or scratching (histamine response)
  • Flushed or warm skin
  • Nausea and vomiting
  • Constipation (chronic users)
  • Slowed movements and reaction time

🔸 Overdose Signs (CRITICAL)

  • Extremely slow or stopped breathing
  • Blue or gray lips and fingernails (cyanosis)
  • Unresponsiveness or unconsciousness
  • Gurgling or choking sounds (“death rattle”)
  • Weak or absent pulse
  • Cold, clammy skin
  • Pupils extremely constricted

🔸 Withdrawal Symptoms

  • Dilated pupils
  • Sweating
  • Runny nose and watery eyes
  • Yawning
  • Goosebumps (“cold turkey”)
  • Muscle aches and joint pain
  • Nausea, vomiting, diarrhea
  • Restlessness and agitation
  • Insomnia
  • Anxiety and irritability
  • Elevated heart rate and blood pressure

🔹 SHORT-TERM EFFECTS

  • Pain relief (analgesia)
  • Intense euphoria (“rush”)
  • Sedation and relaxation
  • Reduced anxiety
  • Slowed breathing (respiratory depression)
  • Decreased heart rate
  • Suppression of cough reflex
  • Impaired decision-making
  • Reduced awareness of danger
  • Increased risk of overdose, especially:
    • High doses
    • Mixing with depressants (alcohol, benzos)
  • Temporary sense of well-being followed by drowsiness
  • Nausea and vomiting (especially early use)

🔹 LONG-TERM EFFECTS (DETAILED SYSTEMS BREAKDOWN)


🧠 Brain & Neurological Effects

  • Alteration of reward system (dopamine dysregulation)
  • Reduced natural ability to experience pleasure
  • Strong psychological dependence
  • Cognitive impairment (attention, memory, decision-making)
  • Increased sensitivity to pain over time (opioid-induced hyperalgesia)
  • Emotional blunting
  • Increased risk of depression

🫁 Respiratory System

  • Chronic respiratory depression
  • Reduced oxygen levels (hypoxia)
  • Increased risk of:
    • Brain injury
    • Death
  • Higher risk when combined with:
    • Alcohol
    • Benzodiazepines
  • Sleep-disordered breathing

🫀 Cardiovascular Effects

  • Slowed heart rate
  • Reduced blood pressure
  • Increased risk of fatal overdose due to respiratory failure
  • Increased risk of endocarditis (especially with injection use)

🧬 Infectious Disease Risk (Especially Injection Use)

  • HIV
  • Hepatitis B and C
  • Skin infections and abscesses
  • Collapsed veins
  • Sepsis

🍽️ Gastrointestinal System

  • Chronic constipation
  • Bowel obstruction (severe cases)
  • Nausea and vomiting
  • Reduced appetite
  • Malnutrition

🧬 Hormonal & Endocrine Effects

  • Reduced testosterone levels (in males)
  • Infertility
  • Decreased libido
  • Menstrual irregularities (in females)
  • Hormonal imbalance

🧠 Tolerance, Dependence, and Withdrawal

  • Rapid development of tolerance
  • Need for increasing doses to achieve effect
  • Physical dependence develops quickly
  • Severe withdrawal symptoms drive continued use
  • Withdrawal is rarely fatal but highly distressing

⚠️ Overdose Risk (CRITICAL SECTION)

🔸 Why Overdose Happens:

  • High potency drugs (fentanyl, carfentanyl, nitazenes)
  • Mixing with other depressants
  • Loss of tolerance (after abstinence, jail, detox)
  • Unknown drug contamination

🔸 Fentanyl & Analogs:

  • Fentanyl: ~50–100x stronger than morphine
  • Carfentanyl: extremely potent (used in veterinary sedation)
  • Nitazenes (emerging): even more potent, increasing overdose deaths
  • Often mixed into:
    • Heroin
    • Cocaine
    • Methamphetamine
    • Pressed pills

➡️ Clients often do not know they are using these substances


💉 Medication-Assisted Treatment (MAT)

🔸 Methadone

  • Full opioid agonist
  • Reduces cravings and withdrawal

🔸 Buprenorphine (Suboxone)

  • Partial agonist
  • Ceiling effect reduces overdose risk

🔸 Naltrexone

  • Opioid antagonist
  • Blocks effects of opioids

➡️ MAT is evidence-based and reduces mortality


🔹 HOW THE CLIENT MAY PRESENT (CLINICAL PATTERNS)

  • Appears sedated, tired, or disengaged
  • Frequently “nodding off”
  • Minimizes use (“it’s just pills,” “it’s prescribed”)
  • Strong cravings and fear of withdrawal
  • Cycles of use → withdrawal → relapse
  • Financial instability due to drug-seeking
  • May shift from pills to heroin/fentanyl due to cost
  • History of overdose or near overdose
  • Frequent ER visits or medical complications
  • Legal involvement (possession, theft, etc.)
  • Poor follow-through in treatment without MAT support
  • High relapse risk without structured care
  • May express desire to quit but fear withdrawal intensely

🔥 CLINICAL TAKEAWAYS

  • Opioids = highest overdose risk category
  • Respiratory depression is the primary cause of death
  • Fentanyl has changed the entire risk landscape
  • Loss of tolerance = major danger point
  • MAT is essential—not optional—for many clients
  • Always assess:
    • Type of opioid
    • Route of use
    • Mixing substances
    • Overdose history
Contengut de la classa
Vidèo
Stimulants
Stimulants
lock

🔷 STIMULANTS


🔹 CLINICALLY OBSERVABLE SYMPTOMS (What You Can See)

🔸 Intoxication / Active Use

  • Increased energy and activity
  • Rapid or pressured speech
  • Restlessness or inability to sit still
  • Dilated pupils
  • Decreased appetite
  • Insomnia or lack of sleep
  • Increased confidence or grandiosity
  • Irritability or agitation
  • Repetitive behaviors (picking, pacing, organizing)
  • Jaw clenching or teeth grinding (bruxism)
  • Excessive sweating
  • Elevated heart rate
  • Increased blood pressure
  • Hyperfocus or obsessive attention to tasks
  • Risk-taking or impulsive behavior

🔸 Chronic / Heavy Use Presentation

  • Significant weight loss
  • Poor hygiene or neglect of self-care
  • Skin sores or picking (especially methamphetamine)
  • Dental deterioration (“meth mouth”)
  • Dark circles under eyes
  • Appears sleep-deprived or exhausted
  • Paranoia or suspiciousness
  • Hallucinations (especially tactile—“bugs crawling”)
  • Disorganized or erratic behavior
  • Emotional volatility (rapid mood shifts)

🔸 Withdrawal (“Crash”) Symptoms

  • Extreme fatigue
  • Depression or low mood
  • Increased appetite
  • Hypersomnia (sleeping excessively)
  • Irritability
  • Lack of motivation (anhedonia)
  • Slowed thinking
  • Strong cravings
  • Anxiety

🔹 SHORT-TERM EFFECTS

  • Increased alertness and energy
  • Elevated mood or euphoria
  • Increased confidence and sociability
  • Heightened focus (especially early use)
  • Reduced need for sleep
  • Decreased appetite
  • Increased heart rate and blood pressure
  • Faster breathing
  • Increased body temperature
  • Heightened sensory awareness

⚠️ Short-term risks include:

  • Anxiety and panic
  • Agitation or aggression
  • Impaired judgment
  • Overexertion or dehydration
  • Cardiac strain (heart attack risk even in young users)

🔹 LONG-TERM EFFECTS (DETAILED SYSTEMS BREAKDOWN)


🧠 Brain & Neurological Effects

  • Dopamine system dysregulation
  • Reduced ability to feel pleasure naturally
  • Increased risk of depression
  • Cognitive impairment (attention, memory, decision-making)
  • Chronic anxiety and irritability
  • Psychosis (especially with methamphetamine):
    • Paranoia
    • Delusions
    • Hallucinations
  • Sleep deprivation-related brain dysfunction
  • Increased impulsivity

🫀 Cardiovascular System

  • Chronic high blood pressure
  • Irregular heartbeat (arrhythmias)
  • Increased risk of:
    • Heart attack
    • Stroke
  • Blood vessel damage
  • Cardiomyopathy (heart muscle damage)

🫁 Respiratory Effects

  • Increased breathing rate
  • Risk of respiratory distress (high doses)
  • Damage depending on route (smoking/snorting)

🍽️ Nutritional & Physical Effects

  • Severe appetite suppression
  • Malnutrition
  • Significant weight loss
  • Muscle breakdown (in extreme cases)
  • Dehydration

🦷 Dental & Skin Effects (Especially Methamphetamine)

  • Severe tooth decay (“meth mouth”)
  • Gum disease
  • Dry mouth (reduced saliva)
  • Skin picking leading to:
    • Open sores
    • Infection
    • Scarring

😴 Sleep & Mental Health Effects

  • Chronic insomnia
  • Disrupted sleep-wake cycle
  • Exhaustion masked by continued use
  • Increased anxiety and panic
  • Emotional instability
  • Increased suicide risk during crash phases

🧠 Tolerance, Dependence, and Behavioral Patterns

  • Rapid tolerance development
  • Binge → crash cycle:
    • Extended use (days awake)
    • Followed by severe crash
  • Psychological dependence (strong)
  • Compulsive use patterns
  • Decreased control over behavior

🔹 SPECIFIC SUBSTANCES


🔸 Cocaine

  • Short-acting stimulant
  • Intense but brief euphoria
  • Leads to frequent re-dosing (“binging”)

Unique Risks:

  • Sudden cardiac events
  • Severe crash after use
  • Nasal damage (snorting)

🔸 Methamphetamine

  • Long-acting and highly potent
  • Strong dopamine release

Unique Risks:

  • Severe psychosis
  • Extreme weight loss
  • Skin picking and infections
  • Long-lasting brain changes

🔸 Prescription Stimulants (Adderall, Ritalin)

  • Used medically but often misused

Unique Risks:

  • Overuse for performance or productivity
  • Sleep deprivation
  • Anxiety and burnout
  • Misperception as “safe”

🔹 HOW THE CLIENT MAY PRESENT (CLINICAL PATTERNS)

🔸 Early Stage

  • High-functioning appearance
  • Increased productivity
  • Social and confident
  • Minimizes risk (“it helps me focus”)

🔸 Mid-Stage

  • Sleep problems
  • Irritability
  • Decline in relationships
  • Increased anxiety

🔸 Late Stage

  • Paranoia and psychosis
  • Disorganized thinking
  • Physical deterioration
  • Financial and legal problems
  • Social isolation

🔹 CLINICAL RED FLAGS

  • Staying awake for multiple days
  • Rapid weight loss
  • Paranoia or hallucinations
  • Aggressive or erratic behavior
  • Repetitive or compulsive actions
  • Severe crash symptoms
  • Mixing with other substances (especially opioids → overdose risk)

🔥 CLINICAL TAKEAWAYS

  • Stimulants push the body beyond normal limits
  • The binge → crash cycle drives addiction
  • Sleep deprivation is a major contributor to:
    • Psychosis
    • Poor decision-making
  • Methamphetamine = highest long-term damage risk in this category
  • Clients may appear functional early—don’t be fooled
  • Always assess:
    • Sleep patterns
    • Duration of use (binges)
    • Presence of paranoia or hallucinations
Contengut de la classa
Vidèo
Cannabis and Hallucinogens
Cannabis and Hallucinogens
lock

🔷 CANNABIS (THC, DELTA PRODUCTS, SYNTHETICS)


🔹 CLINICALLY OBSERVABLE SYMPTOMS (What You Can See)

🔸 Intoxication / Active Use

  • Red or bloodshot eyes
  • Dry mouth (“cotton mouth”)
  • Slowed reaction time
  • Impaired coordination
  • Poor short-term memory
  • Difficulty concentrating
  • Delayed responses in conversation
  • Increased appetite (“munchies”)
  • Lethargy or sedation
  • Laughter or inappropriate affect
  • Anxiety or restlessness (some users)
  • Paranoia or suspiciousness
  • Increased heart rate

🔸 High-Potency / Negative Reaction Signs

  • Panic attacks
  • Severe anxiety
  • Paranoia (“people are watching me”)
  • Disorientation
  • Derealization or depersonalization
  • Hallucination-like experiences (high THC)

🔸 Chronic / Heavy Use Presentation

  • Reduced motivation (“amotivational pattern”)
  • Poor follow-through
  • Memory impairment
  • Emotional flattening or irritability
  • Social withdrawal
  • Sleep disruption
  • Increased baseline anxiety
  • Decline in academic/work performance

🔸 Withdrawal Symptoms

  • Irritability
  • Anxiety
  • Sleep disturbance
  • Decreased appetite
  • Restlessness
  • Mood swings
  • Cravings

🔹 SHORT-TERM EFFECTS

  • Relaxation or euphoria
  • Altered perception of time
  • Heightened sensory awareness
  • Impaired memory and attention
  • Reduced coordination
  • Slowed decision-making
  • Increased appetite
  • Altered judgment

⚠️ Short-term risks:

  • Anxiety and panic
  • Paranoia
  • Impaired driving ability
  • Poor decision-making
  • Risk-taking behaviors

🔹 LONG-TERM EFFECTS (DETAILED SYSTEMS)


🧠 Brain & Cognitive Effects

  • Impaired short-term memory
  • Reduced attention and concentration
  • Slower processing speed
  • Long-term learning difficulties
  • Reduced motivation (in some users)
  • Executive functioning impairment

🧠 Endocannabinoid System (CORE CONCEPT)

  • THC disrupts natural signaling
  • Affects:
    • Mood
    • Memory
    • Appetite
    • Stress response
  • CB1 receptors (brain, CNS) heavily impacted
  • CB2 receptors (immune system) less understood

🧠 Mental Health Effects

  • Increased anxiety over time (in some users)
  • Panic disorder symptoms
  • Depression (especially with heavy use)
  • Increased risk of psychosis

🔸 Adolescent Risk (CRITICAL)

  • Ages ~14–24 = highest vulnerability
  • Increased risk of:
    • Schizophrenia onset
    • Earlier psychosis
  • Higher risk in males
  • May “unmask” underlying conditions

👶 Prenatal / Developmental Effects

  • THC crosses placenta
  • Disrupts fetal endocannabinoid system
  • Increased risk of:
    • Neurodevelopmental issues
    • Attention and behavioral problems
  • Possible increased risk of SIDS
  • Long-term cognitive and emotional impact

🫀 Cardiovascular Effects

  • Increased heart rate
  • Potential strain in vulnerable individuals

🫁 Respiratory Effects (Smoking)

  • Chronic cough
  • Lung irritation
  • Bronchitis-like symptoms

🔬 Synthetic & Delta Products

🔸 Delta-8 / Delta-10

  • Psychoactive (not harmless)
  • Inconsistent potency
  • Often misunderstood as “safe”

⚠️ 2026 Update:

  • Legal loophole closing (Nov 2026)
  • Important for client education

🔸 Synthetic Cannabinoids (K2, Spice)

  • Extremely unpredictable
  • High risk of:
    • Psychosis
    • Severe anxiety
    • Medical emergencies

🔹 HOW THE CLIENT MAY PRESENT

  • Minimizes use (“it’s just weed”)
  • Uses for anxiety, sleep, or stress
  • Denies impairment despite evidence
  • Appears unmotivated or disengaged
  • Struggles with memory or focus
  • Experiences anxiety but continues use
  • Believes it is “safe” or “natural”

🔥 CLINICAL TAKEAWAYS

  • Cannabis ≠ harmless
  • High-potency products change risk profile
  • Adolescents = highest vulnerability
  • Watch for anxiety and psychosis
  • Always assess:
    • Age of first use
    • Frequency
    • Potency
    • Mental health symptoms

🔷 HALLUCINOGENS & DISSOCIATIVES


🔹 CLINICALLY OBSERVABLE SYMPTOMS

🔸 Hallucinogens (LSD, Psilocybin, DMT)

  • Dilated pupils
  • Visual distortions
  • Altered perception of time
  • Emotional intensity
  • Disorganized thinking
  • Confusion
  • Anxiety or panic
  • Rapid mood shifts

🔸 Dissociatives (PCP, Ketamine)

  • Detachment from reality
  • Blank stare
  • Poor coordination
  • Slurred speech
  • Confusion
  • Reduced awareness of surroundings
  • Unpredictable behavior
  • Possible aggression (PCP)

🔹 SHORT-TERM EFFECTS

🔸 Hallucinogens

  • Visual hallucinations
  • Altered perception of reality
  • Heightened emotions
  • Time distortion
  • “Spiritual” or intense experiences

🔸 Dissociatives

  • Detachment from body
  • Reduced pain perception
  • Confusion
  • Impaired motor function

⚠️ Short-term risks:

  • Panic reactions (“bad trips”)
  • Dangerous behavior
  • Injury due to impaired perception
  • Emotional overwhelm

🔹 LONG-TERM EFFECTS


🧠 Brain & Psychological Effects

  • Persistent anxiety
  • Mood instability
  • Cognitive disruption
  • Difficulty distinguishing reality (in severe cases)

🔸 HPPD (Hallucinogen Persisting Perception Disorder)

  • Visual disturbances after use:
    • Trails
    • Flashes
    • Distortions
  • Can last weeks, months, or longer
  • Causes distress and anxiety

🔸 Psychosis Risk

  • Especially with:
    • High doses
    • Repeated use
    • Vulnerable individuals

🔸 DMT (IMPORTANT ADD)

  • Extremely intense, short-acting
  • Causes:
    • Full hallucination immersion
    • Out-of-body experiences
  • Can lead to:
    • Confusion
    • Psychological distress

🔸 PCP Risks

  • Severe behavioral instability
  • Aggression
  • Long-term psychosis

🔸 Ketamine Risks

  • Dissociation
  • Memory impairment
  • Dependency patterns

🔹 HOW THE CLIENT MAY PRESENT

  • Describes experiences as “spiritual” or meaningful
  • May minimize risks
  • Reports unusual sensory experiences
  • Anxiety or panic following use
  • Confusion or disorganized thinking
  • Possible lingering perceptual disturbances
  • Difficulty explaining experiences

🔹 CLINICAL RED FLAGS

  • Persistent visual disturbances
  • Panic reactions
  • Paranoia
  • Risky or dangerous behavior
  • Aggression (PCP)
  • Repeated use despite distress
  • Mixing with other substances

🔥 CLINICAL TAKEAWAYS

  • Hallucinogens alter perception of reality
  • Dissociatives cause detachment from reality
  • Panic reactions can be severe and lasting
  • HPPD is real and often misunderstood
  • DMT = extremely intense, even if short
  • Always assess:
    • Experience during use
    • After-effects
    • Mental health history
Contengut de la classa
Vidèo
Mini-Lesson - Other Emerging Substances
Other Emerging Substances
lock

🔷 EMERGING & “NEW AGE” SUBSTANCES


🔹 MDMA / ECSTASY / MOLLY


🔸 CLINICALLY OBSABLE SYMPTOMS (What You Can See)

  • Dilated pupils
  • Increased energy and movement
  • Excessive talking / sociability
  • Elevated mood or euphoria
  • Jaw clenching / teeth grinding (bruxism)
  • Sweating (often excessive)
  • Flushed skin
  • Increased body temperature
  • Restlessness
  • Dehydration signs (dry lips, fatigue)
  • Emotional openness or vulnerability
  • Reduced personal boundaries
  • Possible confusion at higher doses

🔸 SHORT-TERM EFFECTS

  • Increased serotonin, dopamine, norepinephrine
  • Euphoria and emotional closeness
  • Increased empathy and bonding
  • Heightened sensory perception
  • Increased energy and stamina
  • Reduced inhibition
  • Increased heart rate and blood pressure

⚠️ Risks:

  • Overheating (hyperthermia)
  • Dehydration or overhydration
  • Impaired judgment
  • Risky sexual behavior
  • Serotonin syndrome (especially with SSRIs or other substances)

🔸 LONG-TERM EFFECTS

  • Serotonin depletion (“crash”)
  • Depression and low mood
  • Anxiety
  • Memory and cognitive impairment
  • Sleep disturbances
  • Emotional instability
  • Potential neurotoxicity with repeated use

🔸 HOW THE CLIENT MAY PRESENT

  • Describes use as “safe” or “just for fun”
  • Uses in social/party environments
  • Reports emotional connection experiences
  • Experiences depression after use
  • Minimizes risk due to positive experiences
  • May not realize substance is adulterated

🔹 SYNTHETIC CATHINONES (“BATH SALTS”)


🔸 CLINICALLY OBSERVABLE SYMPTOMS

  • Extreme agitation
  • Rapid speech
  • Paranoia
  • Delusions
  • Hallucinations
  • Aggressive or violent behavior
  • Severe anxiety or panic
  • Sweating
  • Elevated heart rate
  • Confusion

🔸 SHORT-TERM EFFECTS

  • Intense stimulation
  • Increased dopamine activity
  • Euphoria followed by agitation
  • Heightened alertness

⚠️ Risks:

  • Severe psychosis
  • Violent behavior
  • Cardiac events
  • Overheating

🔸 LONG-TERM EFFECTS

  • Persistent psychosis
  • Severe anxiety disorders
  • Cognitive impairment
  • Emotional instability
  • High addiction potential

🔸 HOW THE CLIENT MAY PRESENT

  • Highly unstable or erratic
  • May present in crisis
  • Paranoid or distrustful
  • Disorganized thinking
  • Unpredictable behavior

🔹 “LEAN” (CODEINE + PROMETHAZINE)


🔸 CLINICALLY OBSERVABLE SYMPTOMS

  • Slowed speech
  • Drowsiness
  • Sedation
  • Poor coordination
  • Slowed breathing
  • Constricted pupils (opioid effect)
  • Lethargy
  • Nodding off

🔸 SHORT-TERM EFFECTS

  • Relaxation and euphoria
  • Sedation
  • Reduced anxiety
  • Slowed central nervous system

⚠️ Risks:

  • Respiratory depression
  • Overdose
  • Increased risk when mixed with alcohol or benzos

🔸 LONG-TERM EFFECTS

  • Opioid dependence
  • Tolerance
  • Withdrawal symptoms
  • Respiratory issues
  • Cognitive slowing

🔸 HOW THE CLIENT MAY PRESENT

  • Does not identify use as “opioid use”
  • Minimizes risk (“it’s just syrup”)
  • Appears sedated or disengaged
  • May mix with other depressants

🔹 NITROUS OXIDE (“WHIPPETS”)


🔸 CLINICALLY OBSERVABLE SYMPTOMS

  • Dizziness
  • Disorientation
  • Slurred speech
  • Poor coordination
  • Brief euphoria
  • Confusion
  • Loss of balance

🔸 SHORT-TERM EFFECTS

  • Rapid onset euphoria
  • Dissociation
  • Lightheadedness

⚠️ Risks:

  • Oxygen deprivation (hypoxia)
  • Loss of consciousness
  • Injury from falls

🔸 LONG-TERM EFFECTS

  • Neurological damage
  • Vitamin B12 deficiency
  • Nerve damage
  • Cognitive impairment

🔸 HOW THE CLIENT MAY PRESENT

  • Minimizes use (“it’s not a real drug”)
  • Uses repeatedly due to short duration
  • May not report use unless asked directly

🔹 XYLAZINE (“TRANQ”)


🔸 CLINICALLY OBSERVABLE SYMPTOMS

  • Extreme sedation
  • Slow breathing
  • Unresponsiveness
  • Skin ulcers or wounds
  • Poor healing

🔸 SHORT-TERM EFFECTS

  • Heavy sedation
  • Central nervous system depression

⚠️ Risks:

  • Not reversed by naloxone
  • Severe overdose risk

🔸 LONG-TERM EFFECTS

  • Tissue damage
  • Severe skin wounds
  • Increased mortality risk
  • Compounded overdose risk when mixed with opioids

🔸 HOW THE CLIENT MAY PRESENT

  • Severe physical decline
  • Unexplained wounds
  • Appears heavily sedated
  • History of overdose

🔹 KRATOM


🔸 CLINICALLY OBSERVABLE SYMPTOMS

  • Mild stimulation (low dose)
  • Sedation (higher dose)
  • Nausea
  • Sweating
  • Irritability

🔸 SHORT-TERM EFFECTS

  • Pain relief
  • Mood elevation
  • Energy (low dose)

🔸 LONG-TERM EFFECTS

  • Dependence
  • Withdrawal symptoms (similar to opioids)
  • Anxiety
  • Irritability

🔸 HOW THE CLIENT MAY PRESENT

  • Believes it is “natural and safe”
  • Uses for self-treatment (pain/anxiety)
  • May not recognize dependence

🔹 PHENIBUT


🔸 CLINICALLY OBSERVABLE SYMPTOMS

  • Sedation
  • Calmness
  • Reduced anxiety
  • Slowed thinking

🔸 SHORT-TERM EFFECTS

  • GABA-related calming effect
  • Reduced social anxiety

🔸 LONG-TERM EFFECTS

  • Dependence
  • Severe withdrawal (similar to benzodiazepines)
  • Anxiety rebound
  • Insomnia

🔸 HOW THE CLIENT MAY PRESENT

  • Using for anxiety or sleep
  • Unaware of dependence risk
  • Experiences withdrawal symptoms when stopping

🔹 KEY CLINICAL THEMES (IMPORTANT SUMMARY)

  • Many emerging drugs are:
    • Unregulated
    • Inconsistently dosed
    • Often mixed with other substances
  • Clients frequently:
    • Do not disclose use
    • Do not classify these as “drug use”
    • Believe they are safer than traditional drugs
  • Highest risks:
    • Unknown composition
    • Polysubstance use
    • Misperception of safety

🔥 CLINICAL TAKEAWAYS

  • Always ask specific questions (don’t rely on “do you use drugs?”)
  • Normalize asking about:
    • Syrup
    • Gummies
    • Supplements
    • Party drugs
  • Watch for:
    • Unexplained symptoms
    • Rapid changes in behavior
    • Inconsistent client reports
Contengut de la classa
Vidèo
Pharmacology Made Simple
lock

Final Study Guide & Completion Instructions


🔹 Quiz Completion Requirement

To successfully complete this course and receive your certificate, you must:

  • Complete all lessons in full
  • Pass the final quiz with a score of 70% or higher

If you do not pass on your first attempt, you are encouraged to review this study guide and revisit the lesson materials before retaking the quiz.


🔹 Final Study Guide (Key Concepts to Know)

This summary highlights the most important information from each lesson. Focus on understanding concepts—not memorizing—so you can apply them in real-world counseling situations.


🔷 Lesson 1: Pharmacology Foundations

Pharmacology focuses on how substances move through and affect the body. You should understand the basic processes:

  • Absorption – how a substance enters the bloodstream
  • Metabolism – how the body breaks the substance down (primarily in the liver)
  • Elimination – how the substance leaves the body

You should also clearly understand:

  • Tolerance = needing more of a substance to achieve the same effect
  • Dependence = the body adapts and requires the substance to function normally
  • Withdrawal = physical and psychological symptoms when the substance is reduced or stopped

👉 Key takeaway: Substance use is not just behavioral—it is biological and predictable.


🔷 Lesson 2: Brain & Neurotransmitters

Substances affect the brain by altering neurotransmitters.

  • Dopamine = motivation and reinforcement (not just “pleasure”)
  • GABA = calming/inhibitory (slows the brain)
  • Glutamate = excitatory (speeds up the brain)

The mesolimbic dopamine system drives repeated behavior by reinforcing substance use.

👉 Key takeaway: Addiction is driven by brain learning and motivation systems, not just willpower.


🔷 Lesson 3: Depressants

Depressants (alcohol, benzodiazepines) slow the central nervous system.

  • They increase GABA and decrease glutamate
  • Effects include sedation, impaired coordination, and slowed breathing

Important risks:

  • Withdrawal can be life-threatening (especially seizures)
  • Mixing depressants increases risk of respiratory depression and death

👉 Key takeaway: Depressants are dangerous because they slow vital body functions.


🔷 Lesson 4: Opioids

Opioids affect pain and breathing centers.

  • Primary danger = respiratory depression
  • Overdose risk is extremely high

You should understand:

  • Fentanyl and analogs are extremely potent and often hidden in other drugs
  • Loss of tolerance (after abstinence) greatly increases overdose risk
  • Naloxone reverses opioid overdose by blocking receptors

👉 Key takeaway: Opioids are the highest overdose risk category, especially in today’s drug supply.


🔷 Lesson 5: Stimulants

Stimulants increase central nervous system activity.

  • Increase dopamine and norepinephrine
  • Effects include energy, focus, and decreased need for sleep

Key pattern:

  • Binge → Crash cycle
    • Binge = high energy, no sleep
    • Crash = fatigue, depression, irritability

Risks:

  • Psychosis (especially methamphetamine)
  • Heart problems
  • Severe sleep deprivation

👉 Key takeaway: Stimulants push the body beyond limits and lead to crashes and instability.


🔷 Lesson 6: Cannabis

Cannabis affects the endocannabinoid system, which regulates mood, memory, and stress.

Key concepts:

  • CB1 receptors are located in the brain
  • THC affects memory, attention, and perception

Important risks:

  • Anxiety and paranoia
  • Cognitive impairment
  • Increased risk of psychosis in adolescents, especially males

Additional points:

  • Prenatal exposure can affect fetal brain development
  • Delta-8 and similar products are not harmless

👉 Key takeaway: Cannabis is often minimized, but it has real cognitive and mental health impacts.


🔷 Lesson 7: Hallucinogens & Dissociatives

These substances alter perception and reality.

  • Hallucinogens (LSD, psilocybin) = distort perception
  • Dissociatives (PCP, ketamine) = detach from reality

Key risks:

  • Panic reactions (“bad trips”)
  • Impaired judgment → dangerous behavior
  • HPPD = lasting visual disturbances after use

👉 Key takeaway: These substances affect how reality is experienced, which creates unique risks.


🔷 Lesson 8: Emerging / New Age Substances

These substances are often misunderstood and underreported.

You should recognize:

  • MDMA affects serotonin and emotional connection
  • Lean contains an opioid (codeine) and depressant
  • Bath salts are powerful stimulants
  • Nitrous oxide can cause oxygen deprivation

Key issue:

  • Many of these substances are unregulated and unpredictable

👉 Key takeaway: Always ask specific questions—clients may not identify these as “drug use.”

🔹 How to Access Your Certificate

Once you have completed all lessons and passed the final quiz, your certificate will be available through Coursify.

📍 Where to Find Your Certificate

Email Notification:
When you finish all lessons, Coursify.me often sends an automatic email to your registered address with a direct link to view or download your certificate. Be sure to check your inbox (and spam/junk folder if needed).


Student Dashboard:

  1. Log in to your school’s domain:
    👉 grc.coursify.me
  2. Go to the “My Courses” section
  3. Locate this course (it should show 100% completion)
  4. Click on the course to open it
  5. On the course summary page, look for the:
    👉 “Download Certificate” button or link

🔹 Important Reminder

  • Certificates are only issued after full course completion + passing quiz score
  • If your certificate is not visible, double-check that:
    • All lessons are marked complete
    • Your quiz score meets the 70% requirement

🔹 Final Note

This course was designed to give you practical, real-world pharmacology knowledge you can immediately apply in your work with clients. If needed, revisit the lesson materials and handouts to strengthen your understanding and clinical confidence.

Examen
Certificat

A prepaus del cors

Earn 6 CEU's approved by the Georgia Addiction Counselors Association.


Pharmacology Made Simple
 is a comprehensive, counselor-focused training designed to simplify the science of how substances affect the brain and body—and translate that knowledge into real-world clinical application. This course goes beyond memorizing drug categories by helping participants understand the why behind substance use, addiction patterns, and client behavior.

Participants will explore major substance classes including depressants, opioids, stimulants, cannabis, hallucinogens, and emerging drugs such as MDMA, synthetic substances, and commonly overlooked street and retail drugs. Each section breaks down how substances impact neurotransmitters, brain systems, physical functioning, and behavior—while connecting those effects directly to assessment, treatment planning, and client education.

Special emphasis is placed on clinically relevant topics such as overdose risk, withdrawal patterns, polysubstance use, developmental vulnerabilities (including adolescent and prenatal exposure), and the increasing unpredictability of today’s drug supply. The course also addresses real-world counseling challenges, including client minimization, misperceptions about “safe” substances, and identifying red flags that require further intervention or referral.

Designed specifically for addiction counselors and helping professionals, this training prioritizes practical understanding over complex medical jargon. By the end of the course, participants will be able to more accurately assess substance use patterns, educate clients with confidence, recognize risk factors, and apply pharmacological knowledge in a way that enhances both clinical effectiveness and client safety.

Mai d'info

A prepaus de l'ensenhaire

Desiree Cochran-Norfolk

Assessor/Counselor

Desiree Cochran is a Certified Addiction Counselor II, Certified Clinical Supervisor, and Certified Master Addiction Counselor through the Georgia Addiction Counselor's Association and is a certified anger management facilitator through the Department of Community Supervision. She is also certified as a MCAP through the Florida Certification Board. She completed her Masters in Addiction Counseling at Liberty University. She is certified to teach DUI school, parenting, ASAM treatment for all levels, and all Prime Solutions Classes including the marijuana course. Desiree is also training to become a certified facilitator for the Georgia Commission on Family Violence to facilitate Domestic Violence Intervention Programs.

Georgia Reentry Center

Learn online with Georgia Reentry Center